期刊
THERAPEUTIC INNOVATION & REGULATORY SCIENCE
卷 51, 期 5, 页码 612-619出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/2168479017706405
关键词
patient involvement roadmap; patient input
资金
- Amgen Europe GmbH
- Novartis Farma S.p.A.
The value of patient involvement (PI) in medicines research and development (R&D) is increasingly recognized by all health stakeholders. Despite numerous ongoing PI initiatives, PI so far lacks structure and consistency in approach. Limited formal documentation of PI activities further hampers the sharing of experience and learnings, preventing timely and systematic implementation. This article summarizes the outcomes of several multistakeholder discussions during 2013-2016 in a practical roadmap for PI in medicines R&D. The roadmap highlights specific opportunities for PI along the 4 key stages of the medicines R&D life cycle and is illustrated with concrete examples. This roadmap's aim is to provide a tool to facilitate PI during medicines research and development and is being shared to encourage implementation and further refinement.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据